Why the study?
Most patients with a first unprovoked VTE do not experience recurrence, prompting efforts to identify scoring tools that discriminate subsets of patients who can safely discontinue long-term anticoagulation.
Does the PADIS-PE score safely identify patients who can stop anticoagulation after a first unprovoked PE?
Does the PADIS-PE score safely identify patients who can stop anticoagulation after a first unprovoked PE?
The PADIS-PE score is not supported as a safe tool to identify patients who can discontinue anticoagulation after a first unprovoked pulmonary embolism.
Answers are grounded in this paper and cite their sources.
May refine anticoagulation duration decisions after unprovoked VTE; leaves open need for prospective validation.
Current guidelines suggest that most patients presenting with a first episode of an unprovoked venous thromboembolism (VTE) event be considered for indefinite anticoagulation, as long as their bleeding risk remains acceptably low [1, 2]. However, this exposes a considerable number of patients to long term anticoagulation as 70% of patients with a first unprovoked VTE will have no recurrence [3]. In 2010, a guidance from the International Society on Thrombosis and Haemostasis (ISTH) suggested that a 1-year cumulative rate of recurrent VTE after stopping anticoagulation of less than 5%, with a 95% confidence interval (CI) upper limit lower than 8%, is low enough to consider that long-term anticoagulant therapy would not be beneficial [4]. As such, efforts are ongoing to identify risk factors and scoring tools to help discriminate between subsets of patients whose risk/benefit ratio most- or least-strongly favours continued therapy. This study does not support that the PADIS-PE score can safely identify patients who could stop anticoagulation after a first unprovoked PE <https://bit.ly/3GOzeEl> The REVERSE investigators: P.S. Wells and T. Ramsay, Ottawa, ON, Canada; S.R. Kahn, I. Chagnon and S. Solymoss, Montreal, QC, Canada; D.A. Anderson, Halifax, NS, Canada; M. Crowther, Hamilton, ON, Canada; R. White, Sacramento, CA, USA.
No takes yet. Share an insight, caveat, or question.
Caiano et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: